Evidence map›Paper›PMID 37218914›Full record

ArticlePathophysiology : the official journal of the International Society for Pathophysiology2023

Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period.

Muhammad Vitanata Arfijanto, Tri Pudy Asmarawati, Bramantono Bramantono, Musofa Rusli, Brian Eka Rachman, Bagus Aulia Mahdi, Nasronudin Nasronudin, Usman Hadi

Open access · goldAbstract read
In one paragraph

Article in Pathophysiology : the official journal of the International Society for Pathophysiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Muhammad Vitanata ArfijantoDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.
Tri Pudy AsmarawatiDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.ORCID 0000-0001-9869-5098
Bramantono BramantonoDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.
Musofa RusliDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.ORCID 0000-0002-4834-2259
Brian Eka RachmanDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.
Bagus Aulia MahdiDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.ORCID 0000-0001-6634-6088
Nasronudin NasronudinDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.
Usman HadiDepartment of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya 60132, Indonesia.
Airlangga University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) ribonucleic acid (RNA) shedding is an important parameter for determining the optimal length of isolation period required for coronavirus disease 2019 (COVID-19) patients. However, the clinical (i.e., patient and disease) characteristics that could influence this parameter have yet to be determined. In this study, we aim to explore the potential associations between several clinical features and the duration of SARS-CoV-2 RNA shedding in patients hospitalized with COVID-19. A retrospective cohort study involving 162 patients hospitalized for COVID-19 in a tertiary referral teaching hospital in Indonesia was performed from June to December 2021. Patients were grouped based on the mean duration of viral shedding and were compared based on several clinical characteristics (e.g., age, sex, comorbidities, COVID-19 symptoms, severity, and therapies). Subsequently, clinical factors potentially associated with the duration of SARS-CoV-2 RNA shedding were further assessed using multivariate logistic regression analysis. As a result, the mean duration of SARS-CoV-2 RNA shedding was found to be 13 ± 8.44 days. In patients with diabetes mellitus (without chronic complications) or hypertension, the duration of viral shedding was significantly prolonged (≥13 days;

Indexed as

COVID-19infectious diseaserisk factorsSARS-CoV-2viral shedding

Identifiers

PMID37218914
PMCPMC10204499
OpenAlexW4372349654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.